First-In-Human Phase I Study of a Next-Generation, Oral, TGFb Receptor 1 Inhibitor, LY3200882, in Patients with Advanced Cancer

  1. Yap, T.A.
  2. Vieito, M.
  3. Baldini, C.
  4. Sepúlveda-Sánchez, J.M.
  5. Kondo, S.
  6. Simonelli, M.
  7. Cosman, R.
  8. van der Westhuizen, A.
  9. Atkinson, V.
  10. Carpentier, A.F.
  11. Löhr, M.
  12. Redman, R.
  13. Mason, W.
  14. Cervantes, A.
  15. Le Rhun, E.
  16. Ochsenreither, S.
  17. Warren, L.
  18. Zhao, Y.
  19. Callies, S.
  20. Estrem, S.T.
  21. Man, M.
  22. Gandhi, L.
  23. Avsar, E.
  24. Melisi, D.
Aldizkaria:
Clinical Cancer Research

ISSN: 1557-3265,  1078-0432

Argitalpen urtea: 2021

Alea: 27

Zenbakia: 24

Orrialdeak: 6666-6676

Mota: Artikulua

DOI: 10.1158/1078-0432.CCR-21-1504 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus